Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 7,803 | 81 | 94 | 594 | 2,016 |
| Cost of Goods | 857 | 3 | 2 | 23 | 237 |
| Gross Profit | 6,946 | 78 | 92 | 571 | 1,779 |
| Operating Expenses | 44,795 | 77,621 | 35,057 | 39,535 | 68,888 |
| Operating Income | -36,992 | -77,540 | -34,963 | -38,941 | -66,872 |
| Interest Expense | 2,844 | 2,862 | 1,648 | 3,017 | 2,664 |
| Other Income | 604 | 1,931 | 793 | 1,448 | 523 |
| Pre-tax Income | -39,232 | -78,471 | -35,818 | -40,510 | -69,013 |
| Net Income Continuous | -39,232 | -78,471 | -35,818 | -40,510 | -69,013 |
| Net Income | $-39,232 | $-78,471 | $-35,818 | $-40,510 | $-69,013 |
| EPS Basic Total Ops | -0.28 | -0.58 | -0.26 | -0.30 | -0.51 |
| EPS Basic Continuous Ops | -0.28 | -0.57 | -0.26 | -0.30 | -0.51 |
| EPS Diluted Total Ops | -0.28 | -0.58 | -0.26 | -0.30 | -0.51 |
| EPS Diluted Continuous Ops | -0.28 | -0.57 | -0.26 | -0.30 | -0.51 |
| EBITDA(a) | $-36,711 | $-77,112 | $-34,528 | $-38,389 | $-66,259 |